-
September 9, 2019 Lupin receives U.S. FDA approval for Ethacrynic Acid Tablets USP
-
September 6, 2019 Lupin receives U.S. FDA approval for Fosaprepitant for Injection
-
September 4, 2019 Lupin and Boehringer Ingelheim announce Partnership to Develop and Commercialize Novel Oncology Drug to treat KRAS-driven Cancers
-
August 26, 2019 Lupin’s subsidiary in South Africa announces Commercial Agreement with Creso Pharma for hemp oil based cannaQIX
-
August 22, 2019 Lupin divests Kyowa Criticare to Neopharma group
-
August 22, 2019 Lupin launches Fluoxetine Tablets USP
-
August 16, 2019 Lupin receives U.S. FDA approval for Hydrocortisone Valerate Cream
-
August 8, 2019 U.S. FDA completes inspection of Lupin’s Nagpur facility
-
August 7, 2019 Lupin Quarter I, FY 2020 – Results
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications